Literature DB >> 11752055

Proliferative and morphological effects of endothelins in Schwann cells: roles of p38 mitogen-activated protein kinase and Ca(2+)-independent phospholipase A2.

L N Berti-Mattera1, S Harwalkar, B Hughes, P L Wilkins, K Almhanna.   

Abstract

The regulation of Schwann cell (SC) proliferation and morphology is critical to nerve homeostasis. We have previously reported that endothelins (ETs) regulate the activity of different effectors in SC including adenylyl cyclase, phospholipases C and A2 and mitogen-activated protein kinases (MAPKs). These effects imply a possible participation of ETs in the regulation of SC phenotype. We have now investigated the effects of endothelins on the proliferation and morphology of SC, and compared them with the responses to platelet-derived growth factor (PDGF), a known mitogen in these cells. Both endothelin-1 (ET-1) and PDGF increased the incorporation of [3H]thymidine and the proportion of SC in S and G2/M, with a concomitant decrease in the G0/G1 stage cells. Treatment with ET-1 produced rapid changes in the morphology of the SC, characterized by the appearance of cell spreading with shorter processes. The response to ET-1 was considered to represent a proliferative phenotype, in contrast to the effects of forskolin, which decreased [3H]thymidine incorporation in immortalized SC (iSC) and lead to a differentiated morphology with longer extensions. While both ET-1 and PDGF displayed a proliferative effect on SC, treatment with PDGF did not affect the morphology of these cells to a significant extent. A role for p38 MAPK and Ca(2+)-independent phospholipase A2 in the changes in morphology and proliferation of iSC driven by ET-1 was suggested by the effects of selective inhibitors of these pathways [SB202190 and HELSS, respectively]. The unique pattern of signaling pathways recruited by ET-1 and its combined effects on regulation of phenotype and proliferation of SC suggest an important role for this peptide during nerve degeneration/regeneration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11752055     DOI: 10.1046/j.1471-4159.2001.00642.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Transcriptional profiling in an MPNST-derived cell line and normal human Schwann cells.

Authors:  Philip R Lee; Jonathan E Cohen; Elisabetta A Tendi; Robert Farrer; George H DE Vries; Kevin G Becker; R Douglas Fields
Journal:  Neuron Glia Biol       Date:  2004-05

Review 2.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

Review 3.  Calcium-independent phospholipases A2 and their roles in biological processes and diseases.

Authors:  Sasanka Ramanadham; Tomader Ali; Jason W Ashley; Robert N Bone; William D Hancock; Xiaoyong Lei
Journal:  J Lipid Res       Date:  2015-05-28       Impact factor: 5.922

Review 4.  p38 Mitogen-activated protein kinase regulates myelination.

Authors:  Jeffery D Haines; Gabriela Fragoso; Shireen Hossain; Walter E Mushynski; Guillermina Almazan
Journal:  J Mol Neurosci       Date:  2007-11-10       Impact factor: 3.444

Review 5.  Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death.

Authors:  Xiaoyong Lei; Suzanne E Barbour; Sasanka Ramanadham
Journal:  Biochimie       Date:  2010-01-18       Impact factor: 4.079

6.  Expression changes and bioinformatic analysis of Wallerian degeneration after sciatic nerve injury in rat.

Authors:  Dengbing Yao; Meiyuan Li; Dingding Shen; Fei Ding; Shibi Lu; Qing Zhao; Xiaosong Gu
Journal:  Neurosci Bull       Date:  2013-05-23       Impact factor: 5.203

Review 7.  Calcium-independent phospholipases in the heart: mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunction.

Authors:  Ari Cedars; Christopher M Jenkins; David J Mancuso; Richard W Gross
Journal:  J Cardiovasc Pharmacol       Date:  2009-04       Impact factor: 3.105

8.  Hyperglycemia triggers abnormal signaling and proliferative responses in Schwann cells.

Authors:  Khaldoun Almhanna; Pamela L Wilkins; James R Bavis; Subash Harwalkar; Liliana N Berti-Mattera
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

9.  Endothelin-1 regulates oligodendrocyte development.

Authors:  Ana Gadea; Adan Aguirre; Tarik F Haydar; Vittorio Gallo
Journal:  J Neurosci       Date:  2009-08-12       Impact factor: 6.167

10.  Endothelin-1 as a neuropeptide: neurotransmitter or neurovascular effects?

Authors:  Michael R Dashwood; Andrzej Loesch
Journal:  J Cell Commun Signal       Date:  2009-10-22       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.